 |
25 Diseases |  |
0 Trials |
|
0 Trials |  |
82 News |  |
| «12 |
- |||||||||| aleglitazar (R1439) / Roche
New P3 trial, Combination therapy, Monotherapy: A Study of Aleglitazar in Combination With Metformin in Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Metformin Alone (clinicaltrials.gov) - Sep 23, 2012
P3, N=200, Completed, Sponsor: Hoffmann-La Roche
- ||| aleglitazar (R1439) / Roche
Enrollment change: A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment (clinicaltrials.gov) - Sep 18, 2012
P2, N=302, Completed, Sponsor: Hoffmann-La Roche
N=302302 --> 302
- | aleglitazar (R1439) / Roche
New P2 trial, Monotherapy: A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease (clinicaltrials.gov) - Sep 5, 2012
P2, N=18, Completed, Sponsor: Hoffmann-La Roche
- | aleglitazar (R1439) / Roche
New P1 trial: A Study to Investigate the Effects of Rifampicin on the Pharmacokinetics of Aleglitazar in Healthy Volunteers (clinicaltrials.gov) - Sep 4, 2012
P1, N=24, Completed, Sponsor: Hoffmann-La Roche
- | aleglitazar (R1439) / Roche
New P1 trial, Combination therapy: A Study of Aleglitazar in Combination With Oral Contraceptive Healthy Volunteers (clinicaltrials.gov) - Jun 6, 2012
P1, N=18, Completed, Sponsor: Hoffmann-La Roche
- | aleglitazar (R1439) / Roche
Trial completion: A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar (clinicaltrials.gov) - Oct 13, 2011
P1, N=39, Completed, Sponsor: Hoffmann-La Roche
N=302302 --> 302 Not yet recruiting --> Completed
- | aleglitazar (R1439) / Roche
Trial completion, Combination therapy: A Study of Aleglitazar in Combination With Aspirin in Healthy Volunteers (clinicaltrials.gov) - Sep 18, 2011
P1, N=44, Completed, Sponsor: Hoffmann-La Roche
Not yet recruiting --> Completed Active, not recruiting --> Completed